AU2001261074A1 - Intraperitoneal administration of adenosine for the treatment or prevention of gastrointestinal or systemic diseases - Google Patents

Intraperitoneal administration of adenosine for the treatment or prevention of gastrointestinal or systemic diseases

Info

Publication number
AU2001261074A1
AU2001261074A1 AU2001261074A AU6107401A AU2001261074A1 AU 2001261074 A1 AU2001261074 A1 AU 2001261074A1 AU 2001261074 A AU2001261074 A AU 2001261074A AU 6107401 A AU6107401 A AU 6107401A AU 2001261074 A1 AU2001261074 A1 AU 2001261074A1
Authority
AU
Australia
Prior art keywords
adenosine
gastrointestinal
prevention
treatment
intraperitoneal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261074A
Inventor
Edwin K. Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of AU2001261074A1 publication Critical patent/AU2001261074A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001261074A 2000-04-28 2001-04-30 Intraperitoneal administration of adenosine for the treatment or prevention of gastrointestinal or systemic diseases Abandoned AU2001261074A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20036000P 2000-04-28 2000-04-28
US60200360 2000-04-28
PCT/US2001/013744 WO2001082934A1 (en) 2000-04-28 2001-04-30 Intraperitoneal administration of adenosine for the treatment or prevention of gastrointestinal or systemic diseases

Publications (1)

Publication Number Publication Date
AU2001261074A1 true AU2001261074A1 (en) 2001-11-12

Family

ID=22741390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261074A Abandoned AU2001261074A1 (en) 2000-04-28 2001-04-30 Intraperitoneal administration of adenosine for the treatment or prevention of gastrointestinal or systemic diseases

Country Status (3)

Country Link
US (1) US6566371B2 (en)
AU (1) AU2001261074A1 (en)
WO (1) WO2001082934A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028712A2 (en) * 2001-09-28 2003-04-10 Universite Libre De Bruxelles Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases
US20060079479A1 (en) * 2004-10-13 2006-04-13 Italo Biaggioni Methods of inducing vasodilation
JP2009531367A (en) * 2006-03-31 2009-09-03 アデノバイオ エヌ．フェー． Compositions, methods and kits using adenosine and inosine in combination for diagnosis and treatment
WO2008038094A2 (en) * 2006-09-29 2008-04-03 Wockhardt Research Centre Process for the preparation of pure adenosine
WO2010054068A2 (en) 2008-11-10 2010-05-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cyclic adenosine monophosphates for reducing the formation of adhesions
AU2020341578A1 (en) * 2019-09-05 2022-04-21 TSI Group Co. Ltd. Compositions containing adenosine triphosphate (ATP) and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2007350A6 (en) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Food products enriched with nucleosides and/or nucleotides and preparation thereof.
US5639653A (en) * 1993-07-19 1997-06-17 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy Method for proliferating Vγ2Vδ2 T cells

Also Published As

Publication number Publication date
WO2001082934A1 (en) 2001-11-08
US20020013290A1 (en) 2002-01-31
US6566371B2 (en) 2003-05-20

Similar Documents

Publication Publication Date Title
MXPA03002814A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases.
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
AU2001253265A1 (en) Oral treatment systems
MXPA03010007A (en) Pharmaceutical uses of bisphosphonates.
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
AU2001276860A1 (en) Medicaments for chemotherapeutic treatment of disease
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002358199A1 (en) Shorts or underpants retaining the sexual organs
AU2001281275A1 (en) Processes for the preparation of oligonucleotides
AU2001260834A1 (en) The treatment of herpes
AU2002221099A1 (en) Combination drugs
AU2001243515A1 (en) Combination drug therapy
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AU2001261074A1 (en) Intraperitoneal administration of adenosine for the treatment or prevention of gastrointestinal or systemic diseases
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001262741A1 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU2001275696A1 (en) Therapeutic agent
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU3582101A (en) The treatment of functional gastrointestinal disorders
AU2001248346A1 (en) Use of CDP-choline for the prophylactic treatment of cerebral ischemia
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
AU6106801A (en) Trans-clitoral administration of therapy